In vitro enhancement of NK-cell cytotoxicity against all tumor cell lines and spheroids tested except CHLA90 that expresses less DNAM-1 and H1975 that is generally susceptible to NK-cell-mediated killing. The gene discussed is CD226; the disease is neoplasm.